Search Results - "Burkett, Wesley C."

Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma by Burkett, Wesley C., Zhao, Ziyi, Newton, Meredith A., Sun, Wenchuan, Deng, Boer, Secord, Angeles Alvarez, Zhou, Chunxiao, Bae-Jump, Victoria

“…Uterine serous carcinoma (USC) exhibits worse survival rates compared to the endometrioid subtype, and there is currently no effective treatment options for…”
Get full text

An evaluation of the microbiota of the upper reproductive tract of women with and without epithelial ovarian cancer by Brewster, Wendy R., Burkett, Wesley C., Ko, Emily M., Bae-Jump, Victoria, Nicole McCoy, Amber, Keku, Temitope O.

“…•There is a distinct microbiota of the upper reproductive tract.•There are differences in the microbiota composition between the ovary, fallopian tube, and…”
Get full text

Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial Cancer by Zhao, Ziyi, Wang, Jiandong, Kong, Weimin, Newton, Meredith A, Burkett, Wesley C, Sun, Wenchuan, Buckingham, Lindsey, O'Donnell, Jillian, Suo, Hongyan, Deng, Boer, Shen, Xiaochang, Zhang, Xin, Hao, Tianran, Zhou, Chunxiao, Bae-Jump, Victoria L

“…Epidemiological and clinical evidence have extensively documented the role of obesity in the development of endometrial cancer. However, the effect of fatty…”
Get full text

Fractured and delayed: A qualitative analysis of disruptions in care for gynecologic malignancies during incarceration by Burkett, Wesley C., Iwai, Yoshiko, Gehrig, Paola A., Knittel, Andrea K.

“…Women are experiencing growing rates of incarceration at twice the pace of that for men. Additionally, one-third will be older than 55 years of age by the end…”
Get full text

A Review of Current Management of Placental Site Trophoblastic Tumor and Epithelioid Trophoblastic Tumor by Burkett, Wesley C., Soper, John T.

“…Placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor (ETT) are rare forms of gestational trophoblastic neoplasia (GTN). These tumors…”
Get full text

The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches by Burkett, Wesley C., Clontz, Angela D., Keku, Temitope O., Bae-Jump, Victoria

“…Endometrial cancer (EC) is the most common gynecologic malignancy in the United States, and its incidence and mortality are rising. Obesity is more tightly…”
Get full text

Differences in the microbial profiles of early stage endometrial cancers between Black and White women by Hawkins, Gabrielle M., Burkett, Wesley C., McCoy, Amber N., Nichols, Hazel B., Olshan, Andrew F., Broaddus, Russell, Merker, Jason D., Weissman, Bernard, Brewster, Wendy R., Roach, Jeffrey, Keku, Temitope O., Bae-Jump, Victoria

“…Black women suffer a higher mortality from endometrial cancer (EC) than White women. Potential biological causes for this disparity include a higher prevalence…”
Get full text

Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer by Zhao, Ziyi, Wang, Jiandong, Kong, Weimin, Fang, Ziwei, Coleman, Michael F., Milne, Ginger L., Burkett, Wesley C., Newton, Meredith A., Lara, Olivia, Lee, Douglas, Deng, Boer, Shen, Xiaochang, Suo, Hongyan, Sun, Wenchuan, Hursting, Stephen D., Zhou, Chunxiao, Bae-Jump, Victoria L.

“…Overweight/obesity is the strongest risk factor for endometrial cancer (EC), and weight management can reduce that risk and improve survival. We aimed to…”
Get full text

Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer by Deng, Boer, Kong, Weimin, Suo, Hongyan, Shen, Xiaochang, Newton, Meredith A, Burkett, Wesley C, Zhao, Ziyi, John, Catherine, Sun, Wenchuan, Zhang, Xin, Fan, Yali, Hao, Tianran, Zhou, Chunxiao, Bae-Jump, Victoria L

“…Reprogramming of fatty acid metabolism promotes cell growth and metastasis through a variety of processes that stimulate signaling molecules, energy storage,…”
Get full text

Extending the platinum-free interval: The impact of omitting 2nd line platinum chemotherapy in intermediate platinum-sensitive ovarian cancer by Dockery, Lauren E, Rubenstein, Abby R, Ding, Kai, Mashburn, Sarah G, Burkett, Wesley C, Davis, Allison M, Doo, David W, Arend, Rebecca C, Moore, Kathleen N, Gunderson, Camille C

“…AbstractObjectivesPatients with epithelial ovarian cancer (EOC) recurring between 6 and 12 months after primary platinum chemotherapy have worse prognosis than…”
Get full text

Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? by Beavis, Anna L., Yen, Ting-Tai, Stone, Rebecca L., Wethington, Stephanie L., Carr, Caitlin, Son, Ji, Chambers, Laura, Michener, Chad M., Ricci, Stephanie, Burkett, Wesley C., Richardson, Debra L., Staley, Allison-Stuart, Ahn, Susie, Gehrig, Paola A., Torres, Diogo, Dowdy, Sean C., Sullivan, Mackenzie W., Modesitt, Susan C., Watson, Catherine, Veade, Ashely, Ehrisman, Jessie, Havrilesky, Laura, Secord, Angeles Alvarez, Loreen, Amy, Griffin, Kaitlyn, Jackson, Amanda, Viswanathan, Akila N., Jager, Leah R., Fader, Amanda N.

“…Lymphovascular space invasion (LVSI) is an independent risk factor for recurrence and poor survival in early-stage endometrioid endometrial cancer (EEC), but…”
Get full text